- Glyclopyramide
-
Glyclopyramide Systematic (IUPAC) name 4-chloro-N-[(pyrrolidin-1-ylamino)carbonyl]benzenesulfonamide Clinical data Pregnancy cat. ? Legal status ℞ Prescription only Routes Oral Identifiers ATC code None PubChem CID 71793 UNII KE474IKG1W KEGG D01799 Chemical data Formula C11H14ClN3O3S Mol. mass 303.76 g/mol SMILES eMolecules & PubChem (what is this?) (verify)
Glyclopyramide (INN, marketed under the tradename Deamelin-S) is a sulfonylurea drug used in the treatment of diabetes. It has been marketed in Japan since 1965.
It is classified as second generation.[1]
References
- ^ Ozawa H, Murai Y, Ozawa T (2003). "[A 50-year history of new drugs in Japan-the development and progress of anti-diabetic drugs and the epidemiological aspects of diabetes mellitus]" (in Japanese). Yakugaku Zasshi 38 (1): 11–27. PMID 14570054.
- (Japanese) Deamelin-S 250 mg Tablets
Oral anti-diabetic drugs and Insulin analogs (A10) Insulin K+ ATP1st generation: Acetohexamide • Carbutamide • Chlorpropamide • Tolbutamide • Tolazamide
2nd generation: Glibenclamide (Glyburide)# • Glipizide • Gliquidone • Glyclopyramide • Glimepiride • Gliclazide •Meglitinides/"glinides"GLP-1 analogsfast-acting (Insulin lispro • Insulin aspart • Insulin glulisine) • short-acting (Regular insulin) • long-acting (Insulin glargine • Insulin detemir • NPH insulin) • ultra-long-acting (Insulin degludec†) • inhalable Exubera‡Other Amylin analogSGLT2 inhibitorsOtherBenfluorex‡ • Tolrestat‡This drug article relating to the gastrointestinal system is a stub. You can help Wikipedia by expanding it.